Content equals the label
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
SS-31 50mg Vial
A 50mg vial fill specification for SS-31, supplied under qualified B2B technical evaluation with purity, identity, batch consistency, and lead time planning support.
SS-3150mg vial fillTechnical procurementIdentity documentationBatch documentation
Review specifications, files, and next-step support before requesting samples.
- Confirm the peptide name, CAS, and core specifications
- Check typical applications and document availability
- Use one inquiry path for pricing, files, samples, or project discussion
Key Review Snapshot
Key Review Snapshot
Start with the review points that shape quotation quality.These checkpoints help buyers align file scope, vial format, packaging, MOQ, lead time, and buyer-side review before comparing supplier offers.
Product FormatLyophilized peptide vial
Supply FocusB2B sourcing and documentation review
DocumentationCOA / HPLC / LC-MS / SDS
Quotation ScopeFill amount / vial format / MOQ / lead time
PackagingNeutral label or private-label discussion
ComplianceBuyer-side market review required
Why buyers trust WUMO
Real content, documented — not guesswork
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so SS-31 50mg Vial is backed by documents you can check.
Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.
Every batch is verified
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Documented and traceable
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
Documents Available
COA
Batch-specific COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
HPLC Report
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
MS / Identity Records
Request scope and availability through the B2B inquiry path.
Request this file through the inquiry path below.
SDS
SDS/MSDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Overview
Overview
B2B Review Guide
B2B Review Guide
Product Overview
A 50mg lyophilized vial fill is the specification supplied on this page. Documentation review takes place under qualified B2B technical evaluation.
What WUMO Can Supply
- 50mg SS-31 lyophilized vial fill specification
- Batch-specific COA available under documentation review
- Purity and identity records
- Batch consistency records subject to project confirmation
- Lead time planning discussion
- Controlled or cold-chain shipping discussion where applicable
Quality and Documentation
Documentation that a technical procurement team reviewing SS-31 typically requests includes identity records, HPLC purity records, water content, appearance records, and counter-ion form records. Specific values are subject to batch-specific COA and project confirmation.
Compliance Note
This page is for qualified B2B technical evaluation and business-side documentation review only. This page is not intended for individual purchase, consumer use, or product-use guidance. Final use, importation, labeling, and local compliance are the buyer's responsibility.
FAQ
Why is SS-31 described as a synthetically demanding peptide?
From a sourcing standpoint, SS-31 synthesis carries higher procurement-side requirements around batch consistency and identity verification than standard peptides. This page describes that sourcing-side reality.
What does the 50mg fill specification refer to?
A 50mg vial fill quantity, supplied as a B2B project specification. It is not a use amount.
Why might SS-31 lead time be longer than for other peptides?
Synthesis complexity and batch-level documentation requirements can extend production timelines. Exact lead time ranges are subject to project confirmation.
Does WUMO offer controlled or cold-chain shipping for SS-31?
Controlled or cold-chain shipping options are discussed on a project basis, depending on destination, transit time, and packaging plan.
What documentation can be shared during B2B technical evaluation?
Batch-specific COA, identity records, HPLC purity records, water content records, and counter-ion form records, with scope subject to project confirmation.
OEM / Private Label
Want SS-31 50mg Vial under your own brand?
For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.
Request Pricing, Files, or Samples
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.